title: Testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia: evaluation of pituitary-gonadal function before and after successful testis-sparing surgery in eight patients.
abstract: BACKGROUND
  In male patients with congenital adrenal hyperplasia (CAH), testicular adrenal rest tumors (TART) are frequently present. These tumors can interfere with testicular function. Intensifying glucocorticoid therapy does not always lead to tumor regression and improvement of testicular function. Recently, testis-sparing surgery was introduced for treatment of TART.
  
  
  OBJECTIVE
  The aim of this study was to evaluate tumor volume, symptoms, and pituitary-gonadal function in male patients with CAH caused by 21-hydroxylase deficiency and bilateral TART before and after testis-sparing surgery.
  
  
  METHODS
  This study was conducted at Radboud University Nijmegen Medical Centre in The Netherlands.
  
  
  METHODS
  Eight adult male CAH patients with bilateral TART and infertility were included.
  
  
  METHODS
  Evaluation of testicular magnetic resonance imaging, symptoms, fasting serum concentrations of ACTH, LH, FSH, inhibin B, 17-OH progesterone, androstenedione, testosterone, and estrone, and semen analysis (six of eight patients) was performed before and 6 and 22 months after testis-sparing surgery.
  
  
  METHODS
  The main outcome measures were absence of residual tumor and improvement of symptoms and pituitary-gonadal function.
  
  
  RESULTS
  Residual tumors were not found on any of the patients' magnetic resonance imaging after surgery. Two patients reported testicular pain and discomfort that disappeared after surgery. Parameters of pituitary-gonadal function did not improve after surgery: semen analysis showed azoospermia (five patients) or oligospermia (one patient) without improvement, and all patients had persistently low inhibin B concentrations.
  
  
  CONCLUSIONS
  Testis-sparing surgery did not improve pituitary-gonadal function despite successful removal of the tumors. Further studies are needed to investigate whether surgery at an earlier stage in the natural history of TART can prevent permanent testicular damage.
authors.affiliation: Department of Paediatric Endocrinology, Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. H.Claahsen@cukz.umcn.nl
authors.forename: Hedi L
authors.initials: HL
authors.lastname: Claahsen-van der Grinten
authors.forename: Barto J
authors.initials: BJ
authors.lastname: Otten
authors.forename: Satoru
authors.initials: S
authors.lastname: Takahashi
authors.forename: Eric J H
authors.initials: EJ
authors.lastname: Meuleman
authors.forename: Christina
authors.initials: C
authors.lastname: Hulsbergen-van de Kaa
authors.forename: Fred C G J
authors.initials: FC
authors.lastname: Sweep
authors.forename: Ad R M M
authors.initials: AR
authors.lastname: Hermus
mesh_terms: D019326:17-alpha-Hydroxyprogesterone / Q000097:blood; D000312:Adrenal Hyperplasia, Congenital / Q000473:pathology / Q000503:physiopathology / Q000601:surgery*; D000314:Adrenal Rest Tumor / Q000473:pathology / Q000503:physiopathology / Q000601:surgery*; D000324:Adrenocorticotropic Hormone / Q000097:blood; D000328:Adult; D000735:Androstenedione / Q000097:blood; D053713:Azoospermia / Q000473:pathology / Q000503:physiopathology; D001706:Biopsy; D004970:Estrone / Q000097:blood; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D007265:Inhibins / Q000097:blood; D007986:Luteinizing Hormone / Q000097:blood; D008279:Magnetic Resonance Imaging; D008297:Male; D010902:Pituitary Gland / Q000473:pathology / Q000502:physiology*; D011183:Postoperative Complications / Q000503:physiopathology; D011300:Preoperative Care; D013736:Testicular Neoplasms / Q000473:pathology / Q000503:physiopathology / Q000601:surgery*; D013737:Testis / Q000473:pathology / Q000502:physiology* / Q000601:surgery*; D013739:Testosterone / Q000097:blood; D016896:Treatment Outcome; D013521:Urologic Surgical Procedures, Male / Q000379:methods
chemical_list: C422364:inhibin B; D004970:Estrone; D013739:Testosterone; D000735:Androstenedione; D007265:Inhibins; D019326:17-alpha-Hydroxyprogesterone; D000324:Adrenocorticotropic Hormone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone